Trial Profile
Efficacy and safety of treatment with Anakinra in patients with CINCA/MUCKLE-WELLS syndrome and systemic juvenile idiopathic arthritis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Oct 2012
Price :
$35
*
At a glance
- Drugs Anakinra (Primary)
- Indications Cryopyrin-associated periodic syndromes; Juvenile rheumatoid arthritis
- Focus Therapeutic Use
- 29 Oct 2012 New trial record